MarketCap
Facebook
X
Telegram
ClearPoint Neuro Income Statement 2025-2009 | CLPT
Brief overview of financial performance at ClearPoint Neuro
The comparison covers a five-year financial horizon. According to figures from ClearPoint Neuro, revenue changed from 12.8 million dollars to 37 million dollars over five years. Overall revenue changed by +188.2%, equal to an annualized rate of about 23.6%. The company expanded its revenue base at a high speed.
At the gross-profit level, the result moved from $9.1 million to $22.7 million, a change of +148.8%. The relationship between sales and direct costs deteriorated. At the margin level, the figure shifted from 71.1% to 61.4%. The business retained less gross profit from each unit of revenue.
EBITDA was −5.7 million dollars at the beginning and −23.4 million dollars at the end of the period (−311.8%). Changes in revenue did not translate into comparable EBITDA performance. EBITDA margin moved from −44.2% to −63.2%. A lower EBITDA share weakens the quality of the result.
The net financial result changed from −6.8 million dollars to −25.5 million dollars. The negative result deepened, showing weaker final efficiency.
Over the period, capitalization shifted from 366 million dollars to 316 million dollars (−13.7%). The valuation did not keep pace with the reported progress.
Financial takeaway
The current trajectory does not yet confirm a sustainable recovery. The financial profile benefits from a larger revenue base. Caution is warranted because of lower net income, a narrow EBITDA buffer and a declining EBITDA margin. The key question is whether sales can be converted into sustainable profit.
Annual Income Statement ClearPoint Neuro
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
316 M | 466 M | 149 M | 217 M | 183 M | 366 M | 68.4 M | 30 M | 20.9 M | 7.38 M | 29.4 M | 1.78 B | 3.07 B | 2.71 B | - | - | - |
Shares |
28.3 M | 27 M | 24.6 M | 24.2 M | 20.7 M | 15.5 M | 13.2 M | 10.9 M | 7.74 M | 2.75 M | 1.88 M | 59.2 M | 57.3 M | 40.4 M | - | 6.77 M | - |
Historical Prices |
11.2 | 17.2 | 6.05 | 8.96 | 8.83 | 23.6 | 5.2 | 2.6 | 3 | 2.68 | 15.6 | 30 | 54.4 | 67.2 | - | - | - |
Net Income |
-25.5 M | -18.9 M | -22.1 M | -16.4 M | -14.4 M | -6.78 M | -5.54 M | -6.16 M | -7.17 M | -8.07 M | -8.45 M | -4.52 M | -7.09 M | -5.88 M | -8.31 M | -9.45 M | - |
Revenue |
37 M | 31.4 M | 24 M | 20.6 M | 16.3 M | 12.8 M | 11.2 M | 7.35 M | 7.38 M | 5.75 M | 4.59 M | 122 K | 82 K | 5.06 M | 3.82 M | 2.67 M | - |
Cost of Revenue |
14.3 M | 12.3 M | 10.3 M | 7.02 M | 5.18 M | 3.71 M | 3.94 M | 2.43 M | 2.9 M | - | - | - | - | - | - | - | - |
Gross Profit |
22.7 M | 19.1 M | 13.6 M | 13.5 M | 11.1 M | 9.12 M | 7.38 M | 4.92 M | 4.48 M | 3.11 M | 2.61 M | -1.81 M | -1.34 M | 4.5 M | 3.16 M | - | - |
Operating Income |
-24.2 M | -19.7 M | -22.4 M | -16.3 M | -13.4 M | -6.22 M | -4.59 M | -5.25 M | -6.34 M | -7.49 M | -8.97 M | -5.32 M | -7.47 M | -3.13 M | -5.92 M | -9.52 M | - |
Interest Expense |
-146 K | -40 K | -29 K | 81 K | 973 K | 1.44 M | 955 K | 980 K | 873 K | 1.05 M | 1.26 M | 1.02 M | 500 K | 2.59 M | 2.5 M | 1.59 M | - |
EBITDA |
-23.4 M | -18.8 M | -21.8 M | -16.1 M | -13.2 M | -5.67 M | -4.45 M | -5.14 M | -6.22 M | -8.14 M | -8.76 M | -4.61 M | -6.91 M | -3.4 M | -5.57 M | -9.25 M | - |
Operating Expenses |
- | - | - | - | - | 15.3 M | 12 M | 10.2 M | 10.8 M | 10.6 M | 10.3 M | 11.3 M | 9.98 M | 7.63 M | 9.08 M | - | - |
General and Administrative Expenses |
16.5 M | 12 M | 11.8 M | 9.61 M | 8 M | 5.27 M | 4.3 M | 4.33 M | 4.05 M | - | - | - | - | - | - | 4.7 M | - |
All numbers in USD currency
Quarterly Income Statement ClearPoint Neuro
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
30.2 M | 29.5 M | 28.4 M | 28.3 M | 27.7 M | 27.6 M | 27.6 M | 27.5 M | 25.5 M | 24.7 M | 24.6 M | 24.6 M | 24.6 M | 24.6 M | 24.5 M | 24 M | 23.7 M | 23.7 M | 22.5 M | 21.5 M | 18.9 M | 17 M | 15.7 M | 15.5 M | 15.4 M | 15.2 M | 14.1 M | 12.3 M | 11 M | 11 M | 11 M | 11 M | 10.7 M | 10.7 M | 10.3 M | 6.32 M | 3.62 M | 3.62 M | 2.78 M | 1.97 M | 2.29 M | 2.28 M | 1.87 M | 74.8 M | 74.8 M | 74.8 M | 59 M | 58.9 M | 58.7 M | 58.5 M | 58.3 M | 57.4 M | 54.9 M | 48.1 M | 47.5 M | 40.6 M | 25.2 M | 16.1 M | 16 M | 15.9 M | 15.9 M |
Net Income |
-11.3 M | -9.55 M | -5.89 M | -5.84 M | -6.03 M | - | -4.97 M | -4.41 M | -4.15 M | - | -4.81 M | -7.05 M | -5.61 M | - | -3.79 M | -4.3 M | -3.96 M | - | -3.98 M | -3.74 M | -2.54 M | - | -1.48 M | -1.66 M | -2.06 M | - | -1.12 M | -1.55 M | -1.22 M | - | -1.43 M | -1.88 M | -1.64 M | - | -1.43 M | -2 M | -1.66 M | - | -2.56 M | -1.78 M | -2.04 M | - | -245 K | -3.06 M | -3.95 M | - | -3.65 M | -1.59 M | 2.63 M | - | -3.19 M | -1.35 M | -824 K | - | -5.88 M | -5.88 M | -5.88 M | - | -8.31 M | -8.31 M | -2.25 M |
Revenue |
10.9 M | 12.1 M | 8.86 M | 9.22 M | 8.48 M | - | 8.12 M | 7.86 M | 7.64 M | - | 5.76 M | 5.95 M | 5.43 M | - | 5.15 M | 5.2 M | 5.03 M | - | 4.57 M | 3.41 M | 4.03 M | - | 3.52 M | 2.48 M | 12.8 M | - | 2.93 M | 2.61 M | 2.47 M | - | 1.81 M | 1.65 M | 1.62 M | - | 1.72 M | 1.98 M | 2.01 M | - | 1.62 M | 1.1 M | 1.39 M | - | 1.25 M | 826 K | 1.01 M | - | 633 K | 1.19 M | 823 K | - | 927 K | 562 K | 1.26 M | - | 1.13 M | 1.08 M | 980 K | - | 1.15 M | 723 K | 776 K |
Cost of Revenue |
4.17 M | 4.37 M | 3.26 M | 3.66 M | 3.35 M | - | 3.28 M | 2.87 M | 3.11 M | - | 2.49 M | 2.82 M | 2.23 M | - | 1.47 M | 1.94 M | 1.8 M | - | 1.53 M | 1.14 M | 1.42 M | - | 903 K | 802 K | 932 K | - | 983 K | 1.03 M | 886 K | - | 553 K | 602 K | 589 K | - | 689 K | 798 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
6.71 M | 7.76 M | 5.6 M | 5.56 M | 5.13 M | - | 4.85 M | 4.99 M | 4.52 M | - | 3.27 M | 3.13 M | 3.2 M | - | 3.68 M | 3.26 M | 3.23 M | - | 3.04 M | 2.27 M | 2.61 M | - | 2.62 M | 1.68 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-10.2 M | -8.48 M | -5.28 M | -5.68 M | -6.16 M | - | -5.16 M | -4.72 M | -4.22 M | - | -4.9 M | -7.13 M | -5.71 M | - | -3.8 M | -4.2 M | -3.86 M | - | -3.8 M | -3.41 M | -2.18 M | - | -1.27 M | -1.48 M | -1.21 M | - | -911 K | -1.29 M | -972 K | - | -1.21 M | -1.64 M | -1.43 M | - | -1.33 M | -1.82 M | -1.35 M | - | -1.71 M | -2.06 M | -1.93 M | - | -1.93 M | -2.68 M | -2.94 M | - | -2.62 M | -2.22 M | 2.19 M | - | -1.86 M | -2.18 M | -1.37 M | - | -1.02 M | -3.13 M | -1.15 M | - | -1.43 M | -1.47 M | -1.71 M |
Interest Expense |
-7 K | -35 K | -64 K | -52 K | 4 K | - | -11 K | 5 K | -26 K | - | -12 K | -2 K | -11 K | - | -25 K | -8 K | 11 K | - | 62 K | 240 K | 332 K | - | 201 K | 197 K | 842 K | - | 213 K | 259 K | 254 K | - | 247 K | 248 K | 247 K | - | 211 K | 213 K | 213 K | - | 240 K | 251 K | 345 K | - | 317 K | 312 K | 308 K | - | 289 K | 284 K | 151 K | - | 128 K | 130 K | 106 K | - | 85.8 K | 96 K | 2.33 M | - | 706 K | 598 K | 542 K |
EBITDA |
-10 M | -8.39 M | - | - | -6.06 M | - | - | - | -3.97 M | - | - | - | -5.58 M | - | -3.57 M | -4.02 M | -3.78 M | - | -3.69 M | -3.34 M | -2.17 M | - | -1.1 M | -1.36 M | -1.15 M | - | -805 K | -1.22 M | -938 K | - | -1.12 M | -1.58 M | -1.4 M | - | -1.23 M | -1.76 M | -1.32 M | - | -1.58 M | -1.97 M | -1.89 M | - | -1.77 M | -2.55 M | -2.86 M | - | -2.32 M | -2.01 M | 2.28 M | - | -1.52 M | -1.95 M | -1.25 M | - | -707 K | -2.92 M | -1.05 M | - | -1.18 M | -1.33 M | -1.64 M |
General and Administrative Expenses |
5.55 M | 5 M | 3.59 M | 3.39 M | 4.08 M | - | 3.14 M | 2.76 M | 2.83 M | - | 2.9 M | 3.18 M | 2.96 M | - | 2.4 M | 2.66 M | 2.18 M | - | 2.44 M | 1.98 M | 1.66 M | - | 1.25 M | 1.21 M | 1.28 M | - | 1.03 M | 1.03 M | 933 K | - | 1.08 M | 1.09 M | 953 K | - | 867 K | 936 K | 984 K | - | 1.89 M | 1.89 M | 1.97 M | - | 2.13 M | 2.19 M | 2.29 M | - | 2.06 M | 1.93 M | 1.8 M | - | 1.7 M | 1.7 M | 1.63 M | - | 1.44 M | 1.8 M | 1.34 M | - | 1.37 M | 1.11 M | 1.24 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company ClearPoint Neuro (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
France
China
Israel
Britain
Canada
